ReviewClinical ophthalmology (Auckland, N.Z.)2026
Advances of Intraocular Fluid for the Application and Treatment of Uveitis.
Review in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uveitis is a group of inflammatory eye diseases, which may affect the iris, ciliary body, choroid and other structures, and in severe cases may lead to vision loss. Due to the variety of causes and complex pathogenesis of uveitis, the empirical use of drugs in the absence of clear etiology is likely to be counterproductive and delay the patient's condition. In recent years, the analysis of intraocular fluid (including aqueous humor and vitreous body) has made significant progress in the diagnosis, etiology research and treatment of uveitis. Therefore, this review summarized the latest research progress of intraocular fluid in uveitis, especially its application in etiological diagnosis, biomarkers and treatment strategies, hoping to provide new insights for the clinical diagnosis and treatment of uveitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.